Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
4.000
-0.200 (-4.76%)
Jun 16, 2026, 2:53 PM HKT
-23.22% (1Y)
| Market Cap | 775.40M -5.4% |
| Revenue (ttm) | 74.40M -38.0% |
| Net Income | -94.29M |
| EPS | -0.49 |
| Shares Out | 193.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 600 |
| Open | 4.100 |
| Previous Close | 4.200 |
| Day's Range | 3.890 - 4.100 |
| 52-Week Range | 3.890 - 8.400 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 27, 2026 |